These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 8810766
21. Advances in the treatment and prophylaxis of Pneumocystis carinii pneumonia. Warren E, George S, You J, Kazanjian P. Pharmacotherapy; 1997; 17(5):900-16. PubMed ID: 9324180 [Abstract] [Full Text] [Related]
22. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ. Leoung GS, Stanford JF, Giordano MF, Stein A, Torres RA, Giffen CA, Wesley M, Sarracco T, Cooper EC, Dratter V, Smith JJ, Frost KR, American Foundation for AIDS Research (amfAR) Community-Based Clinical Trials Network. J Infect Dis; 2001 Oct 15; 184(8):992-7. PubMed ID: 11574913 [Abstract] [Full Text] [Related]
23. Low incidence of community-acquired pneumonia among human immunodeficiency virus-infected patients after interruption of Pneumocystis carinii pneumonia prophylaxis. Eigenmann C, Flepp M, Bernasconi E, Schiffer V, Telenti A, Bucher H, Wagels T, Egger M, Furrer H, Swiss HIV Cohort Study. Clin Infect Dis; 2003 Apr 01; 36(7):917-21. PubMed ID: 12652393 [Abstract] [Full Text] [Related]
26. [Desensitization to trimethoprim-sulfamethoxazole in patients with HIV infection]. Piketty C, Gilqouin J, Kazatchkine M. Ann Med Interne (Paris); 1996 Apr 01; 147(5):327-30. PubMed ID: 9033734 [Abstract] [Full Text] [Related]
30. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). El-Sadr WM, Luskin-Hawk R, Yurik TM, Walker J, Abrams D, John SL, Sherer R, Crane L, Labriola A, Caras S, Pulling C, Hafner R. Clin Infect Dis; 1999 Oct 01; 29(4):775-83. PubMed ID: 10589887 [Abstract] [Full Text] [Related]
31. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine. Venugopalan V, Thornton AC, Steinke DT, Rapp RP, Romanelli F, Feola DJ. Pharmacotherapy; 2009 Apr 01; 29(4):373-82. PubMed ID: 19323617 [Abstract] [Full Text] [Related]
32. Pneumocystis carinii pneumonia in human immunodeficiency virus infected patients in Bombay: diagnosed by bronchoalveolar lavage cytology and transbronchial lung biopsy. Bijur S, Menon L, Iyer E, Deshpande J, Sivaraman A, Vaideeswar P, Mahashur AA. Indian J Chest Dis Allied Sci; 1996 Apr 01; 38(4):227-33. PubMed ID: 9018976 [Abstract] [Full Text] [Related]
34. Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients. Jung AC, Paauw DS. Arch Intern Med; 1994 Nov 14; 154(21):2402-6. PubMed ID: 7979835 [Abstract] [Full Text] [Related]
35. Pneumocystis carinii pneumonia prophylaxis with atovaquone in trimethoprim-sulfamethoxazole-intolerant orthotopic liver transplant patients: a preliminary study. Meyers B, Borrego F, Papanicolaou G. Liver Transpl; 2001 Aug 14; 7(8):750-1. PubMed ID: 11510024 [Abstract] [Full Text] [Related]
36. Prophylaxis with trimethoprim-sulfamethoxazole for human immunodeficiency virus-infected patients: impact on risk for infectious diseases. Dworkin MS, Williamson J, Jones JL, Kaplan JE, Adult and Adolescent Spectrum of HIV Disease Project. Clin Infect Dis; 2001 Aug 01; 33(3):393-8. PubMed ID: 11438910 [Abstract] [Full Text] [Related]